Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2008 2
2010 5
2011 4
2012 3
2013 1
2014 6
2015 7
2016 4
2017 6
2018 11
2019 7
2020 5
2021 6
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
Odia Y, Koschmann C, Vitanza NA, de Blank P, Aguilera D, Allen J, Daghistani D, Hall M, Khatib Z, Kline C, MacDonald T, Mueller S, Faison SL, Allen JE, Naderer OJ, Ramage SC, Tarapore RS, McGovern SL, Khatua S, Zaky W, Gardner SL. Odia Y, et al. Among authors: khatua s. Neuro Oncol. 2024 May 3;26(Supplement_2):S155-S164. doi: 10.1093/neuonc/noae001. Neuro Oncol. 2024. PMID: 38400780 Free PMC article. Clinical Trial.
Aptamers in neuro-oncology: An emerging therapeutic modality.
Doherty C, Wilbanks B, Khatua S, Maher LJ 3rd. Doherty C, et al. Among authors: khatua s. Neuro Oncol. 2024 Jan 5;26(1):38-54. doi: 10.1093/neuonc/noad156. Neuro Oncol. 2024. PMID: 37619244 Free PMC article. Review.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Gregory TA, et al. Among authors: khatua s. Neurooncol Adv. 2023 Apr 13;5(1):vdad032. doi: 10.1093/noajnl/vdad032. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37114244 Free PMC article.
Advances in NK cell therapy for brain tumors.
Fares J, Davis ZB, Rechberger JS, Toll SA, Schwartz JD, Daniels DJ, Miller JS, Khatua S. Fares J, et al. Among authors: khatua s. NPJ Precis Oncol. 2023 Feb 15;7(1):17. doi: 10.1038/s41698-023-00356-1. NPJ Precis Oncol. 2023. PMID: 36792722 Free PMC article. Review.
Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials.
Rahman R, Janowski M, Killick-Cole CL, Singleton WGB, Campbell E, Walczak P, Khatua S, Faltings L, Symons M, Schneider JR, Kwan K, Boockvar JA, Gill SS, Oliveira JM, Beccaria K, Carpentier A, Canney M, Pearl M, Veal GJ, Meijer L, Walker DA. Rahman R, et al. Among authors: khatua s. Cancers (Basel). 2023 Jan 30;15(3):857. doi: 10.3390/cancers15030857. Cancers (Basel). 2023. PMID: 36765816 Free PMC article. Review.
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
Gardner SL, Tarapore RS, Allen J, McGovern SL, Zaky W, Odia Y, Daghistani D, Diaz Z, Hall MD, Khatib Z, Koschmann C, Cantor E, Kurokawa R, MacDonald TJ, Aguilera D, Vitanza NA, Mueller S, Kline C, Lu G, Allen JE, Khatua S. Gardner SL, et al. Among authors: khatua s. Neurooncol Adv. 2022 Sep 13;4(1):vdac143. doi: 10.1093/noajnl/vdac143. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36382108 Free PMC article.
Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: Insights from the National Cancer Database.
Kerezoudis P, Yolcu YU, Laack NN, Ruff MW, Khatua S, Daniels DJ, Burns TC, Kizilbash SH. Kerezoudis P, et al. Among authors: khatua s. Neurooncol Adv. 2022 Apr 17;4(1):vdac057. doi: 10.1093/noajnl/vdac057. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35611271 Free PMC article.
78 results